Table 2.

Number of samples tested and proportion with Rotarix® PCV-1 DNA detected, and with Rotarix® RVA RNA detected.

	Among all infants			Among infants with Rotarix RVA RNA detected beyond day 3
Post-vaccination sample day	No. samples tested	No. (%) samples with Rotarix PCV-1 DNA detected	No. (%) samples with Rotarix RVA RNA detected	No. samples tested	No. (%) samples with Rotarix RVA RNA detected
1	32	22 (69)	26 (81)
3	30	12 (40)	20 (67)
5	27	2 (7)	17 (63)	21	17 (81)
7	29	2 (7)	19 (66)	23	19 (83)
9	28	1 (4)	21 (75)	23	21 (91)
11	29	0 (0)	15 (52)	23	15 (65)
13	28	1 (4)	16 (57)	23	16 (70)
15	27	1 (4)	11 (41)	23	11 (48)
30	21	2 (10)	7 (33)	19	7 (37)
45	18	0 (0)	3 (17)	16	4 (25)